Dimensioni, segmenti e analisi del mercato del sequenziamento di nuova generazione (NGS) in oncologia clinica entro il 2025-2031
Clinical Oncology Next Generation Sequencing (NGS) Market Report Analysis
Clinical Oncology Next Generation Sequencing (NGS) Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Agilent Technologies, Inc.
- Caris Life Sciences
- F. Hoffmann-La Roche Ltd
- FOUNDATION MEDICINE, INC.
- Illumina, Inc.
- Myriad Genetics, Inc.
- Oxford Nanopore Technologies
- PerkinElmer Inc
- QIAGEN
Regional Overview
- Nord America
- Europa
- Asia-Pacifico
- America centrale e meridionale
- Medio Oriente e Africa
Market Segmentation
By Tecnologia
- sequenziamento dell'intero esoma
- sequenziamento dell'intero genoma
- sequenziamento e risequenziamento mirati
By Flusso di lavoro
- analisi dei dati NGS
- pre-sequenziamento NGS
- sequenziamento NGS
By Applicazione
- diagnostica complementare
- screening
- altre applicazioni
By Utente finale
- Ospedali e cliniche
- laboratori
Get Free Sample For